Exhibit 5.1
| | |
| | Mayer Brown International LLP 201 Bishopsgate London EC2M 3AF Telephone: +44 20 3130 3000 Fax: +44 20 3130 3001 www.mayerbrown.com DX 556 London and City |
Mereo BioPharma Group plc Fourth Floor One Cavendish Place London W1G 0QF | | 5 August 2021 |
Dear Sirs
Registration Statement on Form F-3
We have acted for Mereo BioPharma Group plc, a public limited company incorporated under the laws of England and Wales (the “Company”), as its legal advisers in England in connection with the registration statement on Form F-3 (the “Registration Statement”) to be filed on or about 5 August 2021 by the Company with the U.S. Securities and Exchange Commission under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and the rules and regulations promulgated thereunder (the “Rules”). The Registration Statement relates to (i) the offering, issuance and sale by the Company from time to time of up to $250,000,000 of indeterminate numbers of ordinary shares of £0.003 each in the Company (“Ordinary Shares”), as may from time to time be offered and sold at indeterminate prices pursuant to the Registration Statement and (ii) the resale by the selling shareholders named in the Registration Statement of 24,493,416 Ordinary Shares from time to time to be sold by such selling shareholders from time to time in the manner set forth in the Registration Statement. The Ordinary Shares are to be offered or sold in the form of American Depositary Shares (“ADSs”). Each ADS represents 5 Ordinary Shares. Up to $50,000,000 of ADSs may be offered, issued and sold by the Company, inter alia, under a open market sale agreement dated 5 August 2021 by and between the Company and Jefferies LLC (the “Sales Agreement”).
In connection with the Registration Statement, we have been asked to provide an opinion on certain matters, as set out below.
This is a legal communication, not a financial communication. Neither this nor any other communication from this firm is intended to be, or should be construed as, an invitation or inducement (direct or indirect) to any person to engage in investment activity.
Mayer Brown International LLP is a limited liability partnership (registered in England and Wales number OC303359), which is authorised and regulated by the Solicitors Regulation Authority with SRA number 369822. Mayer Brown is a global services provider comprising an association of legal practices that are separate entities including Mayer Brown LLP (Illinois, USA), Mayer Brown International LLP (England), Mayer Brown (a Hong Kong partnership) and Tauil & Chequer Advogados (a Brazilian partnership).
We use the term “partner” to refer to a member of Mayer Brown International LLP, or an employee or consultant who is a lawyer with equivalent standing and
qualifications and to a partner of or lawyer with equivalent status in another Mayer Brown entity. A list of the names of members of Mayer Brown International LLP
and their respective professional qualifications may be inspected at our registered office, 201 Bishopsgate, London EC2M 3AF, England or on www.mayerbrown.com.